Giuseppe Mascia1, Roberta Della Bona1, Pietro Ameri1,2, Marco Canepa1,2, Italo Porto1,2, Michele Brignole3. 1. CardioThoracoVascular Department, Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy. 2. Department of Internal Medicine, University of Genoa, Genoa, Italy. 3. Faint and Fall Program, Ospedale San Luca, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Abstract
INTRODUCTION: Distinguishing syncope due to malignant arrhythmias from an incidental benign form in Brugada syndrome (BrS) is often difficult. Through systematic literature review, we evaluated the role of syncope in predicting subsequent malignant arrhythmias in BrS. METHODS: A comprehensive literature search was performed on PubMed (MeSH search terms "Brugada syndrome" and "syncope"). Overall, 9 studies for a total of 1347 patients were included. Patients were stratified as affected by suspected arrhythmic syncope (SAS), undefined syncope (US) or neurally-mediated syncope (NMS). RESULTS: Overall, 15.7% of the 279 patients with SAS had malignant arrhythmic events during a mean follow-up of 67 months, corresponding to 2.8 events per 100/person year. At the same time, 7% of the 527 patients affected by US had malignant arrhythmias during a mean follow-up of 39 months, corresponding 2.2 events per 100/person year. Conversely, 0.7% of 541 patients with NMS had malignant arrhythmic events at follow-up, corresponding to 0.13 events per 100/person year (p = .0001 NMS versus SAS and US pooled). CONCLUSION: In BrS population, the risk of arrhythmic events in the follow-up may be stratified according to the clinical evaluation. The "relatively" low predictive value of the clinical diagnosis of SAS warrants for a more accurate multi-parametric assessment, to restrict the number of candidates for implantable cardioverter-defibrillator therapy.
INTRODUCTION: Distinguishing syncope due to malignant arrhythmias from an incidental benign form in Brugada syndrome (BrS) is often difficult. Through systematic literature review, we evaluated the role of syncope in predicting subsequent malignant arrhythmias in BrS. METHODS: A comprehensive literature search was performed on PubMed (MeSH search terms "Brugada syndrome" and "syncope"). Overall, 9 studies for a total of 1347 patients were included. Patients were stratified as affected by suspected arrhythmic syncope (SAS), undefined syncope (US) or neurally-mediated syncope (NMS). RESULTS: Overall, 15.7% of the 279 patients with SAS had malignant arrhythmic events during a mean follow-up of 67 months, corresponding to 2.8 events per 100/person year. At the same time, 7% of the 527 patients affected by US had malignant arrhythmias during a mean follow-up of 39 months, corresponding 2.2 events per 100/person year. Conversely, 0.7% of 541 patients with NMS had malignant arrhythmic events at follow-up, corresponding to 0.13 events per 100/person year (p = .0001 NMS versus SAS and US pooled). CONCLUSION: In BrS population, the risk of arrhythmic events in the follow-up may be stratified according to the clinical evaluation. The "relatively" low predictive value of the clinical diagnosis of SAS warrants for a more accurate multi-parametric assessment, to restrict the number of candidates for implantable cardioverter-defibrillator therapy.
Authors: Rocío Fernández-Serra; Emma Martínez-Alonso; Alberto Alcázar; Mourad Chioua; José Marco-Contelles; Ricardo Martínez-Murillo; Milagros Ramos; Gustavo V Guinea; Daniel González-Nieto Journal: Int J Mol Sci Date: 2022-07-04 Impact factor: 6.208
Authors: África García-Roy; Ana Sarsa-Gómez; Fátima Méndez-López; Blanca Urdin-Muñoz; María Antonia Sánchez-Calavera Journal: Int J Environ Res Public Health Date: 2022-05-31 Impact factor: 4.614
Authors: Jan-Thorben Sieweke; Jan Hagemus; Saskia Biber; Dominik Berliner; Gerrit M Grosse; Sven Schallhorn; Tobias Jonathan Pfeffer; Anselm A Derda; Jonas Neuser; Johann Bauersachs; Udo Bavendiek Journal: Front Cardiovasc Med Date: 2022-03-08
Authors: Maurice Pradella; Constantin Anastasopoulos; Shan Yang; Manuela Moor; Patrick Badertscher; Julian E Gehweiler; Florian Spies; Philip Haaf; Michael Zellweger; Gregor Sommer; Bram Stieltjes; Jens Bremerich; Stefan Osswald; Michael Kühne; Christian Sticherling; Sven Knecht Journal: PLoS One Date: 2022-08-15 Impact factor: 3.752
Authors: Zhishan Sun; Chengming Fan; Long Song; Hao Zhang; Zenan Jiang; Haoyu Tan; Yaqin Sun; Liming Liu Journal: Front Cardiovasc Med Date: 2022-07-15
Authors: Felix K Wegner; Robert M Radke; Christian Ellermann; Julian Wolfes; Kevin Willy; Philipp S Lange; Gerrit Frommeyer; Helmut Baumgartner; Lars Eckardt; Gerhard-Paul Diller; Stefan Orwat Journal: J Pers Med Date: 2022-03-14